GlassScriptPhysician profile
Daniel Nathan Ginn
NPI 1790002517
$3,280.18
in general payments reported to CMS, 2019-2025
10 companies · $536 in 2025
The $536 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $85.16 · 2021: $30.02 · 2022: $61.35 · 2023: $1,708 · 2024: $577 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,069 · Education: $1,000 · Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,069.21 |
| Education | $1,000.00 |
| Food and Beverage | $752.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,342.85 | 2020-2025 | Davinci Xi, Da Vinci Surgical System |
| Abbvie INC. | $177.44 | 2019 | |
| Hologic Sales and Service, LLC | $177.17 | 2024-2025 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Ethicon US, LLC | $138.31 | 2019-2023 | Stratafix, Surgiflo Hemostatic Matrix |
| Baxter Healthcare | $132.95 | 2023 | Tisseel |
| Sumitomo Pharma America, INC. | $123.43 | 2025 | Myfembree |
| Coopersurgical, INC. | $118.68 | 2019-2025 | Ally II Ups |
| Allergan, INC. | $35.39 | 2019-2020 | |
| Ge Healthcare | $18.95 | 2024 | |
| Duchesnay USA Incorporated | $15.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ginn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.